SCHEMBL6529648

SCHEMBL6529648

COc1ccc(Sc2nc(Nc3cccc(F)c3)nc(N(CCN3CCOCC3)C(=O)[C@@H](N)CC(C)C)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 2/20 0.41
CNR2 P34972 2/20 0.38
POLB P06746 2/20 0.37
GSK3A P49840 1/20 0.37
GSK3B P49841 1/20 0.37
CASR P41180 1/20 0.37
EPHX2 P34913 1/20 0.37
SRC P12931 1/20 0.36
MAPK1 P28482 1/20 0.36
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
USP2 O75604 1/20 0.36
TSHR P16473 1/20 0.36
RECQL P46063 1/20 0.36
BTK Q06187 2/20 0.35
JAK3 P52333 1/20 0.35
AURKA O14965 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6528784 0.95 GALR2 (0.37) PDPK1POLBSRC
SCHEMBL6528279 0.94 GALR2 (0.38) PDPK1SRCHTR2AHTR2CMMP3
SCHEMBL6531968 0.88 POLB (0.39) PDPK1CNR2POLBGSK3AGSK3B
SCHEMBL6528181 0.86 TBK1 (0.35) POLBMAPK1MEN1HTTKMT2A
SCHEMBL6530216 0.86 NPC1 (0.38) POLBMAPK1USP2TSHREGFR
SCHEMBL6528749 0.85 MEN1 (0.37) POLBGSK3AGSK3BMAPK1MEN1
SCHEMBL6531461 0.83 EGFR (0.39) CNR2POLBMEN1KMT2ABTK
SCHEMBL6530876 0.83 MAPT (0.38) POLBMAPK1MEN1KMT2AUSP2
SCHEMBL6533478 0.83 ITK (0.36) POLBMEN1KMT2ATSHREGFR
SCHEMBL6529551 0.82 CHRNA7 (0.35) POLBMAPK1MEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005037828-A1 NOVEL INHIBITORS OF DPP-IV, METHODS OF PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE AGENT LG LIFE SCIENCES LTD. (KR) 2005-04-28 WO disclosed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed